Over the past year, marijuana stocks have been practically unstoppable — and for good reason. For starters, the dollar figures behind the legal cannabis industry are scorching hot.
But they also come with a big fundamental catch.
Though some of the top performers have been cannabinoid-based drug developers, they’re also among the companies losing the most money on an annual basis. In reality, these companies have a lot to prove to earn their current valuations.